TY  - JOUR
AU  - Moñux Ducaju, Guillermo
AU  - Zamorano León, José Javier
AU  - Marqués Pablo
AU  - Sopeña, Bernardo
AU  - García García, José Manuel
AU  - Laich de Koller, Guillermo
AU  - Calvo Rico, Bibiana
AU  - García Fernández, Miguel Ángel
AU  - Serrano, Javier
AU  - López Farre, Antonio José
PY  - 2017
DO  - 10.1111/BCP.13383
SN  - 0306-5251
UR  - https://hdl.handle.net/20.500.14352/99301
T2  - British Journal of Clinical Pharmacology
AB  - AimsTo evaluate if rivaroxaban, an oral factor Xa (FXa) inhibitor, could modify the expression in vitro of inflammatory and oxidative stress biomarkers in abdominal aortic aneurysmal (AAA) sites showing intraluminal thrombus.MethodsAAA sites with...
LA  - eng
M2  - 2661
PB  - Wiley | British Pharmacological Society
TI  - FXa inhibition by rivaroxaban modifies mechanisms associated with the pathogenesis of human abdominal aortic aneurysms
TY  - journal article
VL  - 83
ER  -